Anne Wojcicki

Anne Wojcicki CNBC Next 25
Benjamin Wachenje

Title: Co-founder and CEO, 23andMe

Born: July 28, 1973, San Mateo, California

Education: BS in biology, Yale University

Early Marker: Spent the last 10 years as a health-care investment analyst, focused mainly on biotech companies.

Big Idea: Named for the 23 pairs of chromosomes in a human cell, 23andMe sells personal genome-cell tests so individuals can explore their DNA. The FDA blocked the company's initial efforts to sell health-related reports that reveal a customer's health condition and genetic background, but the company recently gained approval to offer the service in Canada.

Wave of the Future: Genomics

Latest Special Reports

  • Take an in-depth look at the world of modern medicine - examining the treatments, companies and people making a difference in the way we treat illness and injuries today, and laying the foundation for the medical treatments of tomorrow.

  • Fintech

    From Apple Pay to roboadvisors, the worlds of finance and technology are changing the way we live, work, spend money, and do business.

  • working together

    CNBC Upstart 25 is a new original list of the bright young startups poised to become the great companies of tomorrow.

CNBC25: Rebels, Icons and Leaders